Evidence map›Paper›PMID 42055593›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2026

Differentiating the start of an exacerbation from day-to-day variation in people with COPD: a systematic review.

Shaogi Syam, Arafa Aboelhassan, Malik A Althobiani, Ömer Faruk Uysal, Naif Sulaiman, Amar J Shah, Swapna Mandal, Ali R Mani, Joanna C Porter, John R Hurst

Abstract readSystematic Review
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shaogi SyamUCL Respiratory, University College London, London, UK shaogi.syam.23@ucl.ac.uk.ORCID https://orcid.org/0000-0002-9008-4492
Arafa AboelhassanDepartment of Chest Disease, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID https://orcid.org/0000-0001-8701-2693
Malik A AlthobianiDepartment of Respiratory Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0002-2230-5708
Ömer Faruk UysalUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0009-0004-4201-0941
Naif SulaimanUCL Respiratory, University College London, London, UK.
Amar J ShahRespiratory Medicine, Royal Free Hospital NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-7278-6909
Swapna MandalUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-2232-5880
Ali R ManiNetwork Physiology Lab, University College London, London, UK.ORCID https://orcid.org/0000-0003-0830-2022
Joanna C PorterUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-7307-169X
John R HurstUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-7246-6040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOPD symptoms occur with day-to-day variation. An exacerbation of COPD is a symptom worsening that exceeds these fluctuations and requires systemic treatment. Differentiating the start of an exacerbation from day-to-day disease variation is an unmet research need. We sought to examine the evidence that monitoring daily variation in COPD can differentiate this from the onset of an exacerbation.

methodsA systematic review was conducted across MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature, Institute of Electrical and Electronics Engineers and Cochrane databases, as well as a citation search, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies focused on monitoring daily symptoms and/or physiological parameters in stable COPD. Quality assessments were conducted using the Newcastle-Ottawa Scale and the Cochrane Risk of Bias tool. Findings were qualitatively synthesised, considering essential components.

results22 studies were included in the review. The definitions of exacerbation were diverse across studies. 14 (64%) of the included studies demonstrated that day-to-day variation in symptoms (

conclusionThis review summarises evidence on how day-to-day variation differs from the start of an exacerbation in COPD. The combination of continuous monitoring, reliable measurement tools and a refined algorithm, with personalised baseline and threshold values, yields promising results.

Indexed as

LungPulmonary Disease, Chronic ObstructiveDisease ProgressionFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisRisk FactorsTime Factors

Identifiers

PMID42055593
PMCPMC13126125

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.